SP
Medtronic Inc. announced that it has suspended distribution of the Sprint Fidelis family of defibrillation leads, as there is a possibility of lead fractures. The company suspects Sprint Fidelis lead fracture to be a contributing factor for the death of five of its patients. This news led to a decrease in the company’s stock price; the stock was trading at its lowest level in the last two and half months.